Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines
- PMID: 1900918
- PMCID: PMC359860
- DOI: 10.1128/mcb.11.4.1854-1860.1991
Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines
Abstract
The t(9;22) Philadelphia chromosome translocation fuses 5' regulatory and coding sequences of the BCR gene to the c-ABL proto-oncogene. This results in the formation of hybrid BCR-ABL mRNAs and proteins. The shift in ABL transcriptional control to the BCR promoter may play a role in cellular transformation mediated by this rearrangement. We have functionally localized the BCR promoter to a region 1 kb 5' of BCR exon 1 coding sequences by using a chloramphenicol acetyltransferase reporter gene assay. Nucleotide sequence analysis of this region revealed many consensus binding sequences for transcription factor SP1 as well as two potential CCAAT box binding factor sites and one putative helix-loop-helix transcription factor binding site. No TATA-like or "initiator" element sequences were found. Because of low steady-state levels of BCR mRNA and the high GC content (78%) of the promoter region, definitive mapping of transcription start sites required artificial amplification of BCR promoter-directed transcripts. Overexpression from the BCR promoter in a COS cell system was effective in demonstrating multiple transcription initiation sites. In order to assess the effects of chromosomal translocation on the transcriptional control of the BCR gene, we determined S1 nuclease protection patterns of poly(A)+ RNA from tumor cell lines. No differences were observed in the locations and levels of BCR transcription initiation sites between those lines that harbored the t(9;22) translocation and those that did not. This demonstrates that BCR promoter function remains intact in spite of genomic rearrangement. The BCR promoter is structurally similar to the ABL promoters. Together, this suggests that the structural fusion of BCR-ABL and not its transcriptional deregulation is primarily responsible for the transforming effect of the t(9;22) translocation.
Similar articles
-
Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10722-6. doi: 10.1073/pnas.91.22.10722. Proc Natl Acad Sci U S A. 1994. PMID: 7938018 Free PMC article.
-
Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.Genomics. 1995 May 1;27(1):67-82. doi: 10.1006/geno.1995.1008. Genomics. 1995. PMID: 7665185
-
Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineage.Leuk Lymphoma. 1994 Jan;12(3-4):287-96. doi: 10.3109/10428199409059601. Leuk Lymphoma. 1994. PMID: 8167560
-
The BCR/ABL hybrid gene.Baillieres Clin Haematol. 1987 Dec;1(4):983-99. doi: 10.1016/s0950-3536(87)80035-5. Baillieres Clin Haematol. 1987. PMID: 3332859 Review.
-
The molecular biology of chronic myeloid leukaemia.Leukemia. 1996 May;10(5):751-6. Leukemia. 1996. PMID: 8656667 Review.
Cited by
-
Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3755-9. doi: 10.1073/pnas.90.8.3755. Proc Natl Acad Sci U S A. 1993. PMID: 8475126 Free PMC article.
-
RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.Cancer Sci. 2022 Feb;113(2):529-539. doi: 10.1111/cas.15239. Epub 2021 Dec 28. Cancer Sci. 2022. PMID: 34902205 Free PMC article.
-
Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance.Cell Death Dis. 2021 Oct 5;12(10):908. doi: 10.1038/s41419-021-04209-2. Cell Death Dis. 2021. PMID: 34611140 Free PMC article.
-
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.Mol Cancer. 2015 Jul 16;14:132. doi: 10.1186/s12943-015-0407-0. Mol Cancer. 2015. PMID: 26179066 Free PMC article.
-
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction.Oncotarget. 2016 Dec 20;7(51):84810-84825. doi: 10.18632/oncotarget.13319. Oncotarget. 2016. PMID: 27852045 Free PMC article.
References
Publication types
MeSH terms
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous